CN112402451A - anti-HPV (human papilloma Virus) and HSV (herpes Simplex virus) medicine and preparation method thereof - Google Patents

anti-HPV (human papilloma Virus) and HSV (herpes Simplex virus) medicine and preparation method thereof Download PDF

Info

Publication number
CN112402451A
CN112402451A CN202011410051.3A CN202011410051A CN112402451A CN 112402451 A CN112402451 A CN 112402451A CN 202011410051 A CN202011410051 A CN 202011410051A CN 112402451 A CN112402451 A CN 112402451A
Authority
CN
China
Prior art keywords
hpv
parts
hsv
solution
polysaccharide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202011410051.3A
Other languages
Chinese (zh)
Inventor
陈耕
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hubei Jinggeng Bioengineering Co ltd
Original Assignee
Hubei Jinggeng Bioengineering Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hubei Jinggeng Bioengineering Co ltd filed Critical Hubei Jinggeng Bioengineering Co ltd
Priority to CN202011410051.3A priority Critical patent/CN112402451A/en
Publication of CN112402451A publication Critical patent/CN112402451A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/34Copper; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/14Alkali metal chlorides; Alkaline earth metal chlorides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses

Abstract

The invention discloses an anti-HPV and anti-HSV medicament, which comprises 0.1-2 parts of amino polysaccharide quaternary ammonium salt, 0.2-5 parts of algal polysaccharide, 0.3-1.5 parts of sea salt and 0.3-10 parts of copper phytate according to parts by weight. The anti-HPV and anti-HSV medicament and the preparation method thereof are safe and reliable, can realize effective inhibition of HPV and HSV virus, and are convenient to operate.

Description

anti-HPV (human papilloma Virus) and HSV (herpes Simplex virus) medicine and preparation method thereof
Technical Field
The invention relates to the technical field of HPV and HSV treatment, in particular to an anti-HPV and anti-HSV medicament and a preparation method thereof.
Background
Cervical cancer accounts for the second place of female gynecological malignant tumors, and is an important disease threatening female health, the number of people dying from cervical cancer in China is nearly 5 thousands every year, the research on the etiology of cervical cancer is always paid attention to scholars at home and abroad, and the research finds that the key of causing cervical cancer is HPV infection. HPV belongs to the genus papillomavirus of the family papillomaviraceae and is a spherical, double-stranded circular DNA virus. HPV infects humans primarily by direct or indirect contact with contaminated articles or by sexual transmission. Currently, there is no clinically effective treatment for HPV viruses in cervical mucosal cells. If the patient can quickly turn negative when the HPV is positive, the risk of the patient turning from HPV positive to cervical cancer is undoubtedly reduced to a great extent.
HSV, also known as herpes simplex virus, is very common to people infected with HSV, has an infection rate of 80-90 percent and is the virus which is most likely to invade human bodies. HSV enters the body through mucous membranes of oral cavity, respiratory tract and reproductive tract and is spread by sexual contact and direct close contact. After a host is infected, latent infection is usually established in nerve cells, asymptomatic detoxification can occur after activation, and a transmission chain is maintained in people, so that the circulation is repeated. Currently, therapies are available that help the host immune system to fight herpes viruses itself. The vast majority of therapeutic approaches focus on: fusion of the virion envelope with the host cell plasma membrane is prevented by negatively affecting host cell membrane receptors, or by interfering with glycosylation of viral proteins required for fusion, and by reducing viral replication in the host cell nucleus.
Disclosure of Invention
The invention aims to provide an anti-HPV and anti-HSV medicament and a preparation method thereof, which are safe and reliable, can realize effective inhibition of HPV and HSV virus and are convenient to operate.
In order to achieve the purpose, the invention provides an anti-HPV and anti-HSV medicament, which comprises 0.1 to 2 parts of amino polysaccharide quaternary ammonium salt, 0.2 to 5 parts of algal polysaccharide, 0.3 to 1.5 parts of sea salt and 0.3 to 10 parts of copper phytate according to parts by weight.
Preferably, the components and the proportion by weight comprise 0.2 part of amino polysaccharide quaternary ammonium salt, 4.7 parts of algal polysaccharide, 1.4 parts of sea salt and 0.5 part of copper phytate.
Preferably, the components and the proportion by weight comprise 1.8 parts of amino polysaccharide quaternary ammonium salt, 2.7 parts of algal polysaccharide, 0.6 part of sea salt and 8.7 parts of copper phytate.
Preferably, the components and the proportion by weight comprise 1.3 parts of amino polysaccharide quaternary ammonium salt, 0.4 part of algal polysaccharide, 0.5 part of sea salt and 5.4 parts of copper phytate.
Preferably, the components and the proportion by weight comprise 0.7 part of amino polysaccharide quaternary ammonium salt, 3.2 parts of algal polysaccharide, 0.9 part of sea salt and 3.9 parts of copper phytate.
A preparation method of anti-HPV and anti-HSV drugs, a preparation method of gel-state drugs, comprises the following steps:
s1, mixing carbomer with water, and heating to dissolve carbomer to obtain a solution a for later use; wherein, 5-20 parts of carbomer, and water and carbomer are added in equal amount;
s2, mixing and dissolving copper phytate and water in equal proportion, standing stably, adding sea salt and water, fully dissolving and stirring, and standing for 4-6h to obtain a solution b;
s3, respectively dissolving seaweed polysaccharide and amino polysaccharide quaternary ammonium salt and then mixing to obtain a solution c;
and S4, sequentially adding the solution a, the solution b and the solution c into water, uniformly stirring, and adjusting the pH value to obtain the water-based paint.
A preparation method of anti-HPV and anti-HSV drugs and a preparation method of liquid drugs comprise the following steps:
s1, adding water to dissolve copper phytate, adding sea salt in proportion, uniformly stirring, and standing for 4-6h to obtain a solution a;
s2, respectively dissolving seaweed polysaccharide and amino polysaccharide quaternary ammonium salt and then mixing to obtain a solution b;
and S3, sequentially adding the solution a and the solution b into water, and uniformly stirring to obtain the water-based paint.
Therefore, the anti-HPV and anti-HSV medicament and the preparation method thereof are safe and reliable, can realize effective inhibition of HPV and HSV virus, and are convenient to operate.
The amino polysaccharide quaternary ammonium salt has broad-spectrum bactericidal property, can kill most of bacteria, mold, spores and other microorganisms which are contacted with the amino polysaccharide quaternary ammonium salt, and has strong bactericidal effect on drug-resistant pathogenic bacteria, escherichia coli, pseudomonas aeruginosa, candida albicans, chlamydia trachomatis, gonococcus and the like.
The algal polysaccharide can interfere the process of HPV (human papilloma Virus) absorption and cell infiltration, and can form a non-infectious polysaccharide virus compound for blocking HPV transmission; can also inhibit HPV replication; the immune function of the organism is improved by activating the immunity of the organism or improving the biological response function of the organism; enhancing the functions of T cells, B cells and macrophages.
The sea salt contains various other trace elements, and has antibacterial, antiviral (Ag and Zn ion effects), antiallergic (Mn ion effect), and antiinflammatory (Cu ion effect). Meanwhile, Na ions perform composite crosslinking on the composite copper phytate, and the effect of adjusting the association of the combined frames is achieved.
Sodium ions in the sea salt can be fully introduced into the compound phytic acid ketone to form a new compound component, has the HSV inhibition effect, can directly kill viruses, block the replication and transmission of the viruses and inhibit the cytopathy induced by virus cells. And the composite copper phytate composite compound has the effects of resisting HIV, inhibiting reverse transcriptase, integrase, protease, virus and cell CD4 receptor, inhibiting glycosylation and influencing HIV assembly and release.
The technical solution of the present invention is further described in detail by the following examples.
Detailed Description
The embodiments of the present invention will be further explained below.
The medicine for resisting HPV and HSV consists of amino polysaccharide quaternary ammonium salt 0.1-2 weight portions, algal polysaccharide 0.2-5 weight portions, sea salt 0.3-1.5 weight portions and copper phytate 0.3-10 weight portions.
A preparation method of anti-HPV and anti-HSV drugs, a preparation method of 1000mL gel-state drugs, comprises the following steps:
s1, mixing carbomer with water, and heating to dissolve carbomer to obtain a solution a for later use; wherein, 5-20 parts of carbomer, and water and carbomer are added in equal amount;
s2, mixing and dissolving copper phytate and water in equal proportion, standing stably, adding sea salt and water, fully dissolving and stirring, and standing for 4-6h to obtain a solution b;
s3, respectively dissolving seaweed polysaccharide and amino polysaccharide quaternary ammonium salt and then mixing to obtain a solution c;
and S4, sequentially adding the solution a, the solution b and the solution c into 750mL of water, uniformly stirring, and adjusting the pH value to obtain the water-soluble organic fertilizer.
A preparation method of anti-HPV and anti-HSV drugs, a preparation method of 1000mL liquid drugs, comprises the following steps:
s1, adding water to dissolve copper phytate, adding sea salt in proportion, uniformly stirring, and standing for 4-6h to obtain a solution a;
s2, respectively dissolving seaweed polysaccharide and amino polysaccharide quaternary ammonium salt and then mixing to obtain a solution b;
and S3, sequentially adding the solution a and the solution b into 800mL of water, and uniformly stirring to obtain the water-based paint.
Example one
The medicine for resisting HPV and HSV consists of amino polysaccharide quaternary ammonium salt 0.2 weight portions, algal polysaccharide 4.7 weight portions, sea salt 1.4 weight portions and copper phytate 0.5 weight portions.
Example two
The medicine for resisting HPV and HSV consists of amino polysaccharide quaternary ammonium salt 1.8 weight portions, algal polysaccharide 2.7 weight portions, sea salt 0.6 weight portions and copper phytate 8.7 weight portions.
EXAMPLE III
The medicine for resisting HPV and HSV consists of amino polysaccharide quaternary ammonium salt 1.3 weight portions, algal polysaccharide 0.4 weight portions, sea salt 0.5 weight portions and copper phytate 5.4 weight portions.
Example four
The medicine for resisting HPV and HSV consists of amino polysaccharide quaternary ammonium salt 0.7 weight portions, algal polysaccharide 3.2 weight portions, sea salt 0.9 weight portions and copper phytate 3.9 weight portions.
Comparative example 1
The medicine for resisting HPV and HSV consists of amino polysaccharide quaternary ammonium salt 0.7 weight portions, algal polysaccharide 3.2 weight portions and sea salt 0.9 weight portions. Compared with example four, no copper phytate was added.
Comparative example No. two
The medicine for resisting HPV and HSV consists of amino polysaccharide quaternary ammonium salt 0.7 weight portions, algal polysaccharide 3.2 weight portions, sea salt 0.9 weight portions and copper phytate 0.5 weight portions. Compared with the four examples, the dosage of the copper phytate is low.
Test of
(1) Testing for HPV
The outpatient confirmed low-risk 99 HPV patients were selected and randomly divided into 3 groups including test group one, test group two and test group three, and the gel-state drugs prepared in example four, comparative example one and comparative example two were used respectively, and after 1 month of use, the patient remission rate of test group one was 96%, the patient remission rate of test group two was 10% and the patient remission rate of test group three was 50%.
(2) Testing for HSV
99 HSV patients confirmed in outpatient diagnosis are selected and randomly divided into 3 groups, including a test group I, a test group II and a test group III, and gel-state medicaments prepared in the example IV, the comparative example I and the comparative example II are respectively used, after 1 week of use, the patient remission rate of the test group I is 99%, the patient remission rate of the test group II is 15%, and the patient remission rate of the test group III is 60%.
Therefore, the anti-HPV and anti-HSV medicament and the preparation method thereof are safe and reliable, can realize effective inhibition of HPV and HSV virus, and are convenient to operate.
The foregoing is only a preferred embodiment of the present invention, and it should be noted that modifications can be made by those skilled in the art without departing from the principle of the present invention, and these modifications should also be construed as the protection scope of the present invention.

Claims (7)

1. An anti-HPV and anti-HSV drug, which is characterized in that: the components and the proportion by weight comprise 0.1 to 2 portions of amino polysaccharide quaternary ammonium salt, 0.2 to 5 portions of algal polysaccharide, 0.3 to 1.5 portions of sea salt and 0.3 to 10 portions of copper phytate.
2. An anti-HPV, HSV agent according to claim 1, wherein: the components and the proportion by weight comprise 0.2 part of amino polysaccharide quaternary ammonium salt, 4.7 parts of algal polysaccharide, 1.4 parts of sea salt and 0.5 part of copper phytate.
3. An anti-HPV, HSV agent according to claim 1, wherein: the components and the proportion by weight comprise 1.8 parts of amino polysaccharide quaternary ammonium salt, 2.7 parts of algal polysaccharide, 0.6 part of sea salt and 8.7 parts of copper phytate.
4. An anti-HPV, HSV agent according to claim 1, wherein: the components and the proportion by weight comprise 1.3 parts of amino polysaccharide quaternary ammonium salt, 0.4 part of algal polysaccharide, 0.5 part of sea salt and 5.4 parts of copper phytate.
5. An anti-HPV, HSV agent according to claim 1, wherein: the components and the proportion by weight comprise 0.7 part of amino polysaccharide quaternary ammonium salt, 3.2 parts of algal polysaccharide, 0.9 part of sea salt and 3.9 parts of copper phytate.
6. The preparation method of the anti-HPV and anti-HSV drug is characterized in that the preparation method of the gel-state drug comprises the following steps:
s1, mixing carbomer with water, and heating to dissolve carbomer to obtain a solution a for later use; wherein, 5-20 parts of carbomer, and water and carbomer are added in equal amount;
s2, mixing and dissolving copper phytate and water in equal proportion, standing stably, adding sea salt and water, fully dissolving and stirring, and standing for 4-6h to obtain a solution b;
s3, respectively dissolving seaweed polysaccharide and amino polysaccharide quaternary ammonium salt and then mixing to obtain a solution c;
and S4, sequentially adding the solution a, the solution b and the solution c into water, uniformly stirring, and adjusting the pH value to obtain the water-based paint.
7. The preparation method of the anti-HPV and anti-HSV drug is characterized in that the preparation method of the liquid drug comprises the following steps:
s1, adding water to dissolve copper phytate, adding sea salt in proportion, uniformly stirring, and standing for 4-6h to obtain a solution a;
s2, respectively dissolving seaweed polysaccharide and amino polysaccharide quaternary ammonium salt and then mixing to obtain a solution b;
and S3, sequentially adding the solution a and the solution b into water, and uniformly stirring to obtain the water-based paint.
CN202011410051.3A 2020-12-04 2020-12-04 anti-HPV (human papilloma Virus) and HSV (herpes Simplex virus) medicine and preparation method thereof Pending CN112402451A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011410051.3A CN112402451A (en) 2020-12-04 2020-12-04 anti-HPV (human papilloma Virus) and HSV (herpes Simplex virus) medicine and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011410051.3A CN112402451A (en) 2020-12-04 2020-12-04 anti-HPV (human papilloma Virus) and HSV (herpes Simplex virus) medicine and preparation method thereof

Publications (1)

Publication Number Publication Date
CN112402451A true CN112402451A (en) 2021-02-26

Family

ID=74830415

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011410051.3A Pending CN112402451A (en) 2020-12-04 2020-12-04 anti-HPV (human papilloma Virus) and HSV (herpes Simplex virus) medicine and preparation method thereof

Country Status (1)

Country Link
CN (1) CN112402451A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115381866A (en) * 2022-09-15 2022-11-25 南京天诗蓝盾生物科技有限公司 Gel medicine for inhibiting bacteria and killing HPV and preparation method thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015116375A1 (en) * 2014-01-28 2015-08-06 The Population Council, Inc. Combination product for the prevention of sexually transmitted infections
CN109922865A (en) * 2016-09-14 2019-06-21 Cda研究集团股份有限公司 The method treated using Local Copper ion formulations
CN111484732A (en) * 2020-04-23 2020-08-04 江南大学 Phytate composite flame retardant for polyamide and preparation method thereof
CN111632188A (en) * 2020-06-09 2020-09-08 湖北精耕生物工程有限公司 Seaweed polysaccharide composite biological matrix dressing and preparation method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015116375A1 (en) * 2014-01-28 2015-08-06 The Population Council, Inc. Combination product for the prevention of sexually transmitted infections
CN109922865A (en) * 2016-09-14 2019-06-21 Cda研究集团股份有限公司 The method treated using Local Copper ion formulations
CN111484732A (en) * 2020-04-23 2020-08-04 江南大学 Phytate composite flame retardant for polyamide and preparation method thereof
CN111632188A (en) * 2020-06-09 2020-09-08 湖北精耕生物工程有限公司 Seaweed polysaccharide composite biological matrix dressing and preparation method thereof

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
彭冠杰: "《美白化妆品科学与技术》", 30 June 2019, 中国轻工业出版社, pages: 208 - 209 *
李登清: "《女性更年期宜与忌》", 30 September 2010, 科学技术文献出版社, pages: 33 - 35 *
潘道东: "《功能性食品添加剂》", 31 January 2006, 中国轻工业出版社, pages: 346 - 347 *
王琳: "植酸铜配合物的合成与表征", 《吉林化工学院学报》, vol. 24, no. 2, 15 April 2017 (2017-04-15), pages 1 - 2 *
鄢海燕: "《高职高专‘十三五’规划教材 药剂学 第2版》", 31 January 2018, 江苏科学技术出版社, pages: 206 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115381866A (en) * 2022-09-15 2022-11-25 南京天诗蓝盾生物科技有限公司 Gel medicine for inhibiting bacteria and killing HPV and preparation method thereof

Similar Documents

Publication Publication Date Title
EP3760192B1 (en) Chloroquine gel and preparation method and application therefor
CN1173820A (en) Pharmaceutical composition for the treatment of herpes
CN112402451A (en) anti-HPV (human papilloma Virus) and HSV (herpes Simplex virus) medicine and preparation method thereof
CN101695511B (en) Pomegranate rind extract and production method and application thereof
CN112043688A (en) A composition for preventing and/or treating coronavirus infection
WO2002002130A1 (en) Anti-viral composition
CN105688197A (en) Beriberi treatment drug containing lysozyme
WO2022041634A1 (en) Compound formulation for preventing viral infection, and formulation/usage methods and application thereof
CN114404565B (en) Application of beta-Momordica charantia extract in preparation of anti-human papilloma virus infection drugs
US11534438B2 (en) Composition containing piperacillin, pharmaceutical formulation thereof and use thereof
CA2298762C (en) Therapeutic compositions consisting of clarified multi-filtered soluable sodium silicate in liquid form are found to modify suppressor cells and enhanse the human immune system toprevent recurrence of herpes infections
CN102895282B (en) Isatis root extracting solution and nano-silver bacteriostatic composition
CN101820888A (en) Composition comprising sodium (meta)arsenite for treatment of hepatitis c virus
US9315476B2 (en) Antiviral water-soluble product with anti-HIV effect, based on ionic silver and methylene blue compound; method of its production and examples of HIV-infected patients' treatment
CN112294868B (en) Medicine for inactivating virus, sterilizing and activating immunity of organism
CN103719167A (en) Degerming agent specially used for aeromonas hydrophila water body
CN108992478A (en) The application of Aralia wood extract in medicine preparation
CN101167822B (en) Tibetan medicine bongga extraction and its application in preparing antiviral medicine
CN114588197B (en) Application of composition in preparation of medicine for treating herpes viruses
CN115381866A (en) Gel medicine for inhibiting bacteria and killing HPV and preparation method thereof
CN100361686C (en) Compound hawthorn fruit oral liquid
CN116617254A (en) Anti-pathogenic microorganism composition containing boric acid and nitrite and application thereof
CN117462572A (en) Broad-spectrum antiviral composition and preparation method and application thereof
CN106581052A (en) Application of citrate ions and iron ions to inhibition of RNA viruses
Fedoreyev et al. Antiviral activity of histochrome preparation

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination